Defence ministry to airlift 23 oxygen generation plants from Germany

Several states are reeling from an acute shortage of medical oxygen due to a massive surge in coronavirus cases

oxygen tanks
Representational image
Press Trust of India New Delhi
2 min read Last Updated : Apr 23 2021 | 4:51 PM IST

The defence ministry has decided to airlift 23 mobile oxygen generating plants from Germany as several states reeled under an acute shortage of medical oxygen due to a massive surge in coronavirus cases, officials said Friday.

They said each plant will have a capacity to produce 40 litres of oxygen per minute and 2,400 litres every hour.

Principal Spokesperson in the Defence Ministry A Bharat Bhushan Babu said the plants will be deployed in the Armed Forces Medical Services (AFMS) hospitals treating COVID-19 patients.

The decision by the ministry came four days after Defence Minister Rajnath Singh announced granting emergency financial powers to the three services and other defence agencies to make necessary procurement to enhance medical infrastructure in view of the pandemic.

"Twenty-three mobile oxygen generation plants are being airlifted from Germany. These will be deployed in AFMS hospitals catering to the COVID patients," Babu said.

He said the oxygen generating plants are expected to be airlifted within a week.

Another official said the Indian Air Force has been told to remain ready to keep its transport aircraft ready to bring the plants from Germany once required paper works are completed.

The official said more oxygen generation plants may be procured from abroad.

"The advantage of these plants is that they are easily portable," said Babu.

India is struggling with a second wave of coronavirus infection and hospitals in several states are reeling under shortage of medical oxygen and beds in view of rising COVID-19 cases.

India recorded a one-day tally of 3.32 lakh new coronavirus cases and 2,263 new fatalities, according to official data released on Friday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Apr 23 2021 | 4:48 PM IST

Next Story